| scholarly article | Q13442814 |
| P50 | author | Whitney Townsend | Q61651315 |
| P2093 | author name string | Dinesh Khanna | |
| Nezam Altorok | |||
| Vallerie McLaughlin | |||
| Heather Gladue | |||
| P2860 | cites work | Comparison of the diagnostic utility of cardiac magnetic resonance imaging, computed tomography, and echocardiography in assessment of suspected pulmonary arterial hypertension in patients with connective tissue disease. | Q53161524 |
| Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database | Q56974596 | ||
| Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Clinical characteristics at diagnosis and long-term survival | Q56978019 | ||
| The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France | Q56978153 | ||
| Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study | Q56978308 | ||
| Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era | Q60168168 | ||
| Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis | Q69506384 | ||
| Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis | Q73303815 | ||
| Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis | Q79782391 | ||
| High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis | Q80419679 | ||
| Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis | Q80979404 | ||
| Should patients with connective tissue disease undergo exercise Doppler echocardiography? | Q82787546 | ||
| Usefulness of echocardiography in the identification of an excessive increase in pulmonary arterial pressure in patients with systemic sclerosis | Q83299938 | ||
| Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis | Q83361046 | ||
| Pulmonary hypertension in systemic lupus erythematosus: prevalence, predictors and diagnostic strategy | Q84650986 | ||
| The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews | Q24801517 | ||
| Pulmonary arterial hypertension in connective tissue diseases | Q26866288 | ||
| N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study | Q30463476 | ||
| Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension | Q30562538 | ||
| Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study | Q33834751 | ||
| Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings | Q33861919 | ||
| ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American Coll | Q34977467 | ||
| Diagnosis and assessment of pulmonary arterial hypertension. | Q34989034 | ||
| Mortality and causes of death in a Swedish series of systemic sclerosis patients | Q35547607 | ||
| Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): baseline characteristics and description of study population | Q35591616 | ||
| Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype | Q36752821 | ||
| Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension | Q38511072 | ||
| Significance of plasma N-terminal pro-brain natriuretic peptide in patients with systemic sclerosis-related pulmonary arterial hypertension | Q40547439 | ||
| Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis | Q42969084 | ||
| Pulmonary arterial hypertension associated with systemic sclerosis in the Czech Republic | Q43838385 | ||
| Clinical features and independent predictors of pulmonary arterial hypertension in systemic lupus erythematosus | Q43941028 | ||
| Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations. | Q44262313 | ||
| Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies | Q44577909 | ||
| Clinical differences between idiopathic and scleroderma-related pulmonary hypertension | Q44610192 | ||
| Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus | Q46815469 | ||
| Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. | Q48385253 | ||
| Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension | Q48550363 | ||
| Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease. | Q50803077 | ||
| Is pulmonary arterial hypertension really a late complication of systemic sclerosis? | Q51131925 | ||
| Guidelines for the diagnosis and treatment of pulmonary hypertension. | Q51793640 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | connective tissue | Q25615 |
| arterial hypertension | Q41861 | ||
| P304 | page(s) | 536-541 | |
| P577 | publication date | 2013-09-05 | |
| P1433 | published in | Seminars in Arthritis and Rheumatism | Q15761553 |
| P1476 | title | Screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension: a systematic review | |
| P478 | volume | 43 |
| Q58110373 | Isolated DLco/VA reduction in systemic sclerosis patients: a new patient subset? |
| Q38206152 | Personalized medicine in systemic sclerosis: facts and promises |
| Q40696023 | Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001-2012. |
| Q30562538 | Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension |
Search more.